A technology that enables the analysis of many proteins from a single drop of blood, rapidly and accurately has been developed. The instrumentation has been fully developed and launched as a commercial product. Initial applications have been developed in the field of autoimmune disease. In this project, it is proposed to apply the same methodology to detect autoimmune responses to cancer antigens. This product will be a powerful tool for researchers to detect and characterize tumor associated autoimmune response through disease progression, in a highly qualified automated and standardized instrument workflow. This will enable direct comparisons of data to be made by researchers across the country.

Agency
National Institute of Health (NIH)
Type
Small Business Innovation Research – Phase II (N44)
Project #
261201300081C-0-0-1
Application #
8762812
Study Section
Project Start
2013-09-18
Project End
2015-09-17
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$999,237
Indirect Cost
Name
Genalyte, Inc.
Department
Type
DUNS #
808551472
City
San Diego
State
CA
Country
United States
Zip Code
92121